NCT00533598已完成2 期
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
The purpose of this study is to assess the effects of MK0557 on body weight in obese subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women between 21 and 65 years of age, willing to avoid all prescription and nonprescription medicine to alter body weight for entire study
排除标准
- •You are or plan to become pregnant
- •You have smoked or used nicotine within 6 months of the study
- •History of abusing alcohol and/or drugs
- •History of a stroke, you have diabetes mellitus, you are taking medication for high blood pressure, you have had recent surgery, you have been involved in another study within 3 months of study, use of cholesterol or anti-seizure medication during the study
- •Have participated in a weight loss program 3 months before the study or during the course of the study
研究者
相似试验
终止
2 期
Safety, Toleration and Efficacy of CP-741,952 for the Treatment of ObesityObesityNCT00367783Pfizer100
已完成
2 期
Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)OverweightBody WeightObesityNCT00642993Merck Sharp & Dohme LLC401
已完成
2 期
A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.ObesityNCT01195792GlaxoSmithKline60
已完成
3 期
A Comparative Study of KES524 in Patients With Obesity DiseaseObesityNCT00165685Eisai Limited
已完成
4 期
A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese AdolescentsChildhood ObesityPediatric ObesityNCT02714062VIVUS LLC42